Outlook Therapeutics, Inc. (OTLK) Insider Trading

Name: Outlook Therapeutics, Inc. (OTLK) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 2, 2026): Lundquist Kevin Michael (Chief Financial Officer): Grant/Award of 500,000 shares.

Get alerted when insiders trade OTLK

Email address

Loading company data...

Beta

Loading company details...

Beta